Off-topic for aiqbench
This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.
OpenEvidence raises $250M at $15B, pivots into drug development
Dealroom.co1 min read
OpenEvidence raises $250M at $15B, pivots into drug development Dealroom
Read the full article at Dealroom.co
